Heyu Biological Technology Corporation
HYBT · OTC
9/30/2025 | 6/30/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $148 | $148 | $148 | $148 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $7 | $7 | $7 | $6 |
| Enterprise Value | $155 | $155 | $155 | $154 |
| Revenue | $3 | $4 | $0 | $1 |
| % Growth | -9.7% | 8,204.5% | -94.4% | – |
| Gross Profit | $1 | $1 | $0 | $0 |
| % Margin | 17.5% | 16% | 71.4% | 6.1% |
| EBITDA | $0 | $1 | -$0 | -$0 |
| % Margin | 13% | 14% | -435.4% | -6.1% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 5.7% | 13% | -539.1% | -7.4% |
| EPS Diluted | 0 | 0.001 | -0.001 | -0 |
| % Growth | -60% | 300% | -400% | – |
| Operating Cash Flow | -$0 | -$0 | -$4 | -$4 |
| Capital Expenditures | -$0 | -$0 | $13 | -$11 |
| Free Cash Flow | -$1 | -$0 | $9 | -$15 |